Point-of-care (POC) biosensors are integrated diagnostic systems employed for the detection of clinically relevant analytes in biological fluids such as blood, urine and saliva. These devices offer the advantage to provide rapid results directly where the information is needed, thus facilitating an earlier diagnosis and a prompt patient's treatment. Various technologies have been proposed for the realization of POC biosensors including label-free techniques based on optical, mechanical and electrochemical transducers. However, reliable, quantitative and ultrasensitive devices have been not yet commercialized. Electronic biosensors based on organic thin-film transistors are a promising choice for the development of the next generation of POC devices. The ProSiT proposal takes a tremendous step forward in the development of an unprecedented high-sensitive, label-free, self-powerd, single-molecule detection technology.

2020

2022